These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency. Banga A, Gildea T, Rajeswaran J, Rokadia H, Blackstone EH, Stoller JK. Am J Respir Crit Care Med; 2014 Aug 01; 190(3):274-81. PubMed ID: 25003824 [Abstract] [Full Text] [Related]
3. Alpha-1 antitrypsin Null mutations and severity of emphysema. Fregonese L, Stolk J, Frants RR, Veldhuisen B. Respir Med; 2008 Jun 01; 102(6):876-84. PubMed ID: 18353624 [Abstract] [Full Text] [Related]
4. Alpha-1-antitrypsin deficiency: outcomes after liver transplantation. Kemmer N, Kaiser T, Zacharias V, Neff GW. Transplant Proc; 2008 Jun 01; 40(5):1492-4. PubMed ID: 18589136 [Abstract] [Full Text] [Related]
13. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency. Franciosi AN, Hobbs BD, McElvaney OJ, Molloy K, Hersh C, Clarke L, Gunaratnam C, Silverman EK, Carroll TP, McElvaney NG. Am J Respir Crit Care Med; 2020 Jul 01; 202(1):73-82. PubMed ID: 32197047 [Abstract] [Full Text] [Related]
14. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Dahl M, Nordestgaard BG, Lange P, Vestbo J, Tybjaerg-Hansen A. Clin Chem; 2001 Jan 01; 47(1):56-62. PubMed ID: 11148177 [Abstract] [Full Text] [Related]
18. Long term results of liver transplantation for alpha-1 antitrypsin deficiency. Guillaud O, Jacquemin E, Couchonnal E, Vanlemmens C, Francoz C, Chouik Y, Conti F, Duvoux C, Hilleret MN, Kamar N, Houssel-Debry P, Neau-Cransac M, Pageaux GP, Gonzales E, Ackermann O, Gugenheim J, Lachaux A, Ruiz M, Radenne S, Debray D, Lacaille F, McLin V, Duclos-Vallée JC, Samuel D, Coilly A, Dumortier J. Dig Liver Dis; 2021 May 01; 53(5):606-611. PubMed ID: 33139195 [Abstract] [Full Text] [Related]
19. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients. Turner AM, Stolk J, Bals R, Lickliter JD, Hamilton J, Christianson DR, Given BD, Burdon JG, Loomba R, Stoller JK, Teckman JH. J Hepatol; 2018 Aug 01; 69(2):378-384. PubMed ID: 29572094 [Abstract] [Full Text] [Related]
20. Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis. Al-Jameil N, Hassan AA, Buhairan A, Hassanato R, Isac SR, Al-Otaiby M, Al-Maarik B, Al-Ajeyan I. Medicine (Baltimore); 2017 Feb 01; 96(6):e6071. PubMed ID: 28178162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]